Biotest AG

Common Name
Biotest
Country
Germany
Sector
Healthcare
Industry
Biotechnology
Employees
2,495
Ticker
BIO
Exchange
HANSEATISCHE WERTPAPIERBOERSE HAMBURG
Description
Biotest AG is a biotechnology and pharmaceutical company that specializes in the research, development, and manufacturing of plasma protein products and biotherapeutic drugs. Its primary function is t...

Biotest EU Taxonomy Data Preview

In 2024, Biotest was subject to the Corporate Sustainability Reporting Directive (CSRD)'s requirements, which mandated the company to publish EU Taxonomy disclosures.

The company reported the eligibility and alignment of Turnover, Capital Expenditure (CAPEX) and Operating Expenditure (OPEX) with the EU Taxonomy, helping assess the extent to which its business activities align with Europe's environmental sustainability goals.

Biotest has also provided an activity-level breakdown of its EU Taxonomy disclosures. This granular reporting enhances transparency around which economic activities of Biotest are considered environmentally sustainable and contribute to at least one of the six environmental objectives defined under the EU Taxonomy framework.

Metric (tonnes)2024202320222021 - 2017
Total Taxonomy Aligned A1 Turnover
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Taxonomy Eligible A Turnover
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Taxonomy Non-Eligible B Turnover
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Metric (tonnes)2024202320222021 - 2017
Total Taxonomy Aligned A1 Opex
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Taxonomy Eligible A Opex
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Taxonomy Non-Eligible B Opex
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Metric (tonnes)2024202320222021 - 2017
Total Taxonomy Aligned A1 Capex
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Taxonomy Eligible A Capex
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000
Total Taxonomy Non-Eligible B Capex
0000000
Copy restricted. Please purchase to unlock this data.
Copy restricted. Please purchase to unlock this data.
0000000

This table provides a simplified preview of selected EU Taxonomy data points. To access the complete dataset with full disclosures, detailed breakdowns, and source traceability, create a free account to view purchase options.

Insights into Biotest's Revenues from Sustainable Activities

In 2024, Biotest reported EU Taxonomy-eligible revenues of EUR 592.85 million, representing 81.6% of its total turnover. Of this amount, EUR 0 of Biotest's revenues was classified as EU Taxonomy-aligned, indicating that 0% of the revenue-generating activities undertaken by the company substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).

Insights into Biotest's CAPEX from Sustainable Activities

In 2024, Biotest reported EU Taxonomy-eligible CAPEX of EUR 35.34 million, representing 97.1% of its total CAPEX. Of this amount, EUR 0 of Biotest's CAPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's investments were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).

Insights into Biotest's OPEX from Sustainable Activities

In 2024, Biotest reported EU Taxonomy-eligible OPEX of EUR 69.40 million, representing 87.6% of its total operating expenses (OPEX). Of this amount, EUR 0 of Biotest's OPEX was classified as EU Taxonomy-aligned, indicating that 0% of the company's operating expenses were directed toward economic activities that substantially contribute to one or more of the six environmental objectives, meet the Do No Significant Harm (DNSH) criteria, and comply with the Minimum Social Safeguards (MSS).

Want Full Access to Biotest's EU Taxonomy Dataset?
Sign Up